BACKGROUND: We wished to compare the efficacy of ultrasound versus intravenous contrast-enhanced computed tomography (CT) for detecting recurrent renal cell carcinoma (RCC) by identifying patients presenting with such tumor burden and to evaluate the utility of these imaging modalities in these circumstances. METHODS: Patients who developed local and/or distant recurrences following surgical intervention for RCC were identified. The imaging regimen utilized during post-operative surveillance was analyzed to determine whether recurrent disease was identifiable on ultrasound or CT or both. RESULTS: Of the 22 patients with recurrent RCC, 16 had previously undergone radical nephrectomy and 6 had undergone partial nephrectomy. Median duration to RCC recurrence was 28.5 months (range 2-66 months). Fourteen patients (64%) underwent ultrasound during their follow-up surveillance protocol and 1 case of disease recurrence was detected by ultrasound before subsequent con-frmation with CT. All 22 patients underwent CT as a routine component of their follow-up surveillance protocol and all recurrences were detected by this modality. Six patients had recurrence in their ipsilateral kidney after partial nephrec-tomy - five had undergone ultrasound in their surveillance protocol and this modality failed to detect a recurrence in four of these patients. CONCLUSION: Ultrasound is inferior to CT for detecting recurrent RCC. CT should be recognized as the standard diagnostic modality during post-operative surveillance, in contradiction to what is recommended in many guidelines.
BACKGROUND: We wished to compare the efficacy of ultrasound versus intravenous contrast-enhanced computed tomography (CT) for detecting recurrent renal cell carcinoma (RCC) by identifying patients presenting with such tumor burden and to evaluate the utility of these imaging modalities in these circumstances. METHODS: Patients who developed local and/or distant recurrences following surgical intervention for RCC were identified. The imaging regimen utilized during post-operative surveillance was analyzed to determine whether recurrent disease was identifiable on ultrasound or CT or both. RESULTS: Of the 22 patients with recurrent RCC, 16 had previously undergone radical nephrectomy and 6 had undergone partial nephrectomy. Median duration to RCC recurrence was 28.5 months (range 2-66 months). Fourteen patients (64%) underwent ultrasound during their follow-up surveillance protocol and 1 case of disease recurrence was detected by ultrasound before subsequent con-frmation with CT. All 22 patients underwent CT as a routine component of their follow-up surveillance protocol and all recurrences were detected by this modality. Six patients had recurrence in their ipsilateral kidney after partial nephrec-tomy - five had undergone ultrasound in their surveillance protocol and this modality failed to detect a recurrence in four of these patients. CONCLUSION: Ultrasound is inferior to CT for detecting recurrent RCC. CT should be recognized as the standard diagnostic modality during post-operative surveillance, in contradiction to what is recommended in many guidelines.
Authors: Luca Cindolo; Jean-Jacques Patard; Paolo Chiodini; Luigi Schips; Vincenzo Ficarra; Jacques Tostain; Alexandre de La Taille; Vincenzo Altieri; Bernard Lobel; Richard E Zigeuner; Walter Artibani; François Guillé; Claude C Abbou; Luigi Salzano; Ciro Gallo Journal: Cancer Date: 2005-10-01 Impact factor: 6.860
Authors: Sudish C Murthy; Kwhanmien Kim; Thomas W Rice; Jeevanantham Rajeswaran; Ronald Bukowski; Malcolm M DeCamp; Eugene H Blackstone Journal: Ann Thorac Surg Date: 2005-03 Impact factor: 4.330
Authors: Ahmad H Bani-Hani; Bradley C Leibovich; Christine M Lohse; John C Cheville; Horst Zincke; Michael L Blute Journal: J Urol Date: 2005-02 Impact factor: 7.450
Authors: Pascal Mouracade; Jaya S Chavali; Onder Kara; Julien Dagenais; Matthew J Maurice; Ryan J Nelson; Brian I Rini; Jihad H Kaouk Journal: Urol Oncol Date: 2017-08-31 Impact factor: 3.498
Authors: Lee Richstone; Douglas S Scherr; Victor R Reuter; Mark E Snyder; Farhang Rabbani; Michael W Kattan; Paul Russo Journal: J Urol Date: 2004-02 Impact factor: 7.450